This public procurement record has 2 releases in its history.

Award

12 Sep 2024 at 16:51

Tender

31 May 2024 at 16:05

Summary of the contracting process

NHS England has completed the award stage for its NHS National Framework for the supply of Ustekinumab, under procurement reference CM/TNS/24/5711. This framework is designed to cover the supply of pharmaceutical products, specifically Ustekinumab, across different regions in the UK. The contract is divided into two lots: CM/TNS/24/5711/01, covering London and the South of England from 1 September 2024 to 31 August 2026, and CM/TNS/24/5711/02, covering the North of England, Midlands, and the East from 1 September 2024 to 31 August 2025. Both lots have options to extend for up to a total of 24 months at the Authority’s discretion. The procurement was conducted via an open procedure and included a framework agreement. NHS Medicines Value & Access, part of NHS England, is the contracting authority overseeing this process.

This tender presents significant opportunities for pharmaceutical companies specialising in the supply of biological medicines. The framework's substantial value, coupled with its national reach, offers businesses a robust platform for growth. Companies such as Amgen, Sandoz, Thornton and Ross, Celltrion Healthcare, Janssen-Cilag, and Accord-UK, who have been awarded contracts, illustrate the range of suppliers from large companies to SMEs that can compete in this market. Businesses with a focus on pharmaceutical products, particularly those adept at competitive pricing, are well-suited to participate and benefit from the opportunities provided by this framework agreement. The open procurement process and framework arrangement ensure a transparent and competitive environment, fostering innovation and efficiency in the supply chain.

How relevant is this notice?

Notice Title

NHS National Framework for the supply of Ustekinumab - 1 September 2024

Notice Description

Project title: NHS National Framework for the supply of Ustekinumab 1 September 2024<br/><br/>Offer reference number: CM/TNS/24/5711<br/><br/>CM/TNS/24/5711/01 - NHS Framework for the supply of Ustekinumab - London & South of England. Period of framework: 1 September 2024 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.<br/><br/>CM/TNS/24/5711/02 - NHS Framework for the supply of Ustekinumab - North of England and Midlands & East. Period of framework: 1 September 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.<br/><br/>Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Lot Information

CM/TNS/24/5711/01 - NHS Framework for the supply of Ustekinumab - London & South

CM/TNS/24/5711/01 - NHS Framework for the supply of Ustekinumab - London & South of England. Period of framework: 1 September 2024 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

CM/TNS/24/5711/02 - NHS Framework for the supply of Ustekinumab - North & MAE

CM/TNS/24/5711/02 - NHS Framework for the supply of Ustekinumab - North of England and Midlands & East. Period of framework: 1 September 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-046cc5
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/029292-2024
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£579,000,000 £100M-£1B
Lots Value
£579,000,000 £100M-£1B
Awards Value
Not specified
Contracts Value
£1

Notice Dates

Publication Date
12 Sep 20241 years ago
Submission Deadline
1 Jul 2024Expired
Future Notice Date
Not specified
Award Date
13 Aug 20242 years ago
Contract Period
1 Sep 2024 - 31 Aug 2025 6-12 months
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LEEDS
Postcode
LS1 4AP
Postcode Area
Leeds
Country
England

Major Region (ITL 1)
TLE Yorkshire and The Humber
Basic Region (ITL 2)
TLE4 West Yorkshire
Small Region (ITL 3)
TLE42 Leeds
Delivery Location
Not specified

Local Authority
Leeds
Electoral Ward
Hunslet & Riverside
Westminster Constituency
Leeds South

Supplier Information

Number of Suppliers
6
Supplier Names

Accord-UK Ltd

Amgen Ltd

Celltrion Healthcare United Kingdom Limited

Janssen-Cilag Ltd

Sandoz Ltd

Thornton and Ross Ltd

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...